Effects of Yishen Yangsui formula() on pyroptosis in the spinal cord tissue in rats with degenerative cervical myelopathy.
10.12200/j.issn.1003-0034.20240880
- Author:
Guo-Liang MA
1
;
He YIN
1
;
Bo XU
1
;
Min-Shan FENG
1
;
Dan ZHANG
2
;
Dian ZHANG
1
;
Xiao-Kuan QIN
1
;
Li-Guo ZHU
3
;
Bo-Wen YANG
1
;
Xin CHEN
1
Author Information
1. Wangjing Hospital, China Academy of Traditional Chinese Medicine, Beijing 100102, China.
2. Shared Instrument Platform of Biomedical Testing Center, Tsinghua University, Beijing 100804, China.
3. Wangjing Hospital, China Academy of Traditional Chinese Medicine, Beijing 100102, China; Beijing Key Laboratory of Bone Setting Technology of Traditional Chinese Medicine, Beijing 100700, China.
- Publication Type:Journal Article
- Keywords:
Inflammatory response;
Pyroptosis;
Rats;
Spinal cord injury;
Yishen Yangsui formula
- MeSH:
Animals;
Female;
Drugs, Chinese Herbal/administration & dosage*;
Rats;
Rats, Sprague-Dawley;
Pyroptosis/drug effects*;
Spinal Cord/pathology*;
NLR Family, Pyrin Domain-Containing 3 Protein;
Spinal Cord Diseases/drug therapy*;
Interleukin-1beta/metabolism*
- From:
China Journal of Orthopaedics and Traumatology
2025;38(5):532-539
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To preliminarily investigate the effects and mechanism of action of Yishen Yangsui Formula (, YSYSF)on the recovery of neurological function in rats with degenerative cervical myelopathy.
METHODS:Fifty adult SD female rats were randomly divided into control group, sham group, model group, YSYSF group and positive drug group by using randomized numerical table method. In the model group, YSYSF group and positive drug group, polyvinyl alcohol acrylamide interpenetrating network hydrogel(water-absorbent swelling material) was used to construct a rat spinal cord chronic compression model. The sham group was implanted with the water-absorbent swelling material and then removed without causing spinal cord compression. The control group, the sham group and the model group were given equal amounts of saline by gavage, the group of YSYSF was given Chinese herbal medicine soup by gavage 9.1 g·kg-1 once a day, and the positive drug group was given tetrahexylsalicylglucoside sodium monosialate ganglioside by intraperitoneal injection 4.2 mg·kg-1 once a day. The motor function of the rats was assessed by the BBB method after 1, 3, 7, and 14 d of drug administration. The spinal cord tissues were taken from rats executed 14 d after drug administration, and the morphological changes of the spinal cord compression site were observed by HE staining, and the expression levels of Caspase-1, GSDMD, NLRP3, PYCARD, IL-1β, and IL-18 were detected in the area of spinal cord injury by Western blot method.
RESULTS:The BBB scores of the control group and the sham group were normal at all time points after modeling, which were higher than the BBB scores of the model group, the YSYSF, and the positive drug group (P<0.05). From the 3rd day after gavage, at all time points, the BBB scores of rats in the YSYSF group and the positive drug group were higher than those of rats in the model group (P<0.05). The staining pattern of HE spinal cord tissue was normal in the control group and the sham group, and the HE spinal cord in the model group was severely damaged with a large number of neuron deaths, whereas the damage to the spinal cord and neuron cells was reduced in the YSYSF group and the positive drug group. The expression levels of caspase-1, GSDMD, NLRP3, PYCARD, IL-1β and IL-18 in the spinal cord of the model group were significantly higher than those of the sham group (P<0.0001), and the expression levels of caspase-1, GSDMD, NLRP3, PYCARD, IL-1β, and IL-18 in the YSYSF group and the drug group were significantly lower than those in the model group (P<0.05).
CONCLUSION:YSYSF can improve the motor function of rats with degenerative cervical spinal cord disease, alleviate the pathological changes, and promote the recovery of spinal cord neurological function. The specific mechanism may be related to the inhibition of the activation of inflammatory vesicles NLRP3 and PYCARD, the reduction of the release of inflammatory factors IL-1β and IL-18, the reduction of the expression of caspase-1 and GSDMD, the reduction of cellular death, and the inhibition of inflammatory response.
